Cargando…

Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis

BACKGROUND: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. OBJECTIVE: We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinsbø, Øyvind, Carlsen, Arne, Aasprong, Ole Gunnar, Aabakken, Lars, Tvedt-Gundersen, Espen, Bjørkhaug, Steinar, Gjerde, Rune, Normann Karlsen, Lars, Grimstad, Tore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729989/
https://www.ncbi.nlm.nih.gov/pubmed/36506747
http://dx.doi.org/10.1177/17562848221140659
_version_ 1784845583930884096
author Steinsbø, Øyvind
Carlsen, Arne
Aasprong, Ole Gunnar
Aabakken, Lars
Tvedt-Gundersen, Espen
Bjørkhaug, Steinar
Gjerde, Rune
Normann Karlsen, Lars
Grimstad, Tore
author_facet Steinsbø, Øyvind
Carlsen, Arne
Aasprong, Ole Gunnar
Aabakken, Lars
Tvedt-Gundersen, Espen
Bjørkhaug, Steinar
Gjerde, Rune
Normann Karlsen, Lars
Grimstad, Tore
author_sort Steinsbø, Øyvind
collection PubMed
description BACKGROUND: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. OBJECTIVE: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. DESIGN: This was a prospective cohort study. METHODS: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. RESULTS: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). CONCLUSION: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates.
format Online
Article
Text
id pubmed-9729989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97299892022-12-09 Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis Steinsbø, Øyvind Carlsen, Arne Aasprong, Ole Gunnar Aabakken, Lars Tvedt-Gundersen, Espen Bjørkhaug, Steinar Gjerde, Rune Normann Karlsen, Lars Grimstad, Tore Therap Adv Gastroenterol Original Research BACKGROUND: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. OBJECTIVE: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. DESIGN: This was a prospective cohort study. METHODS: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. RESULTS: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). CONCLUSION: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates. SAGE Publications 2022-12-06 /pmc/articles/PMC9729989/ /pubmed/36506747 http://dx.doi.org/10.1177/17562848221140659 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Steinsbø, Øyvind
Carlsen, Arne
Aasprong, Ole Gunnar
Aabakken, Lars
Tvedt-Gundersen, Espen
Bjørkhaug, Steinar
Gjerde, Rune
Normann Karlsen, Lars
Grimstad, Tore
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_full Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_fullStr Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_full_unstemmed Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_short Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_sort histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729989/
https://www.ncbi.nlm.nih.gov/pubmed/36506747
http://dx.doi.org/10.1177/17562848221140659
work_keys_str_mv AT steinsbøøyvind histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT carlsenarne histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT aasprongolegunnar histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT aabakkenlars histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT tvedtgundersenespen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT bjørkhaugsteinar histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT gjerderune histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT normannkarlsenlars histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT grimstadtore histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis